INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Corporate insider
KB

Klein Matthew B.

Director, CHIEF EXECUTIVE OFFICERCIK 0001808968

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score27
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$202K
2,850 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    PTC THERAPEUTICS, INC.Director, CHIEF EXECUTIVE OFFICER · Jan 2, 2026
14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL
$192K
2,514 sh
Jan 8, 2026
Jan 12, 2026
traded Jan 8, 2026
+4d
SEC FORM 4

Evidence

17
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$396K
5,149 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$234K
3,016 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC FORM 4

Evidence

27
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$620K
8,089 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC FORM 4

Evidence